Trials / Unknown
UnknownNCT03542123
Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- NeuroTronik Inc. · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A single-arm study to observe NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System hemodynamic and other physiologic effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NeuroTronik CANS Therapy® System | The NeuroTronik CANS Therapy® System is a percutaneous, catheter-based, bedside electrical stimulation system. The System consists of the single-use, disposable NeuroCatheter™ and NeuroCatheter™ Placement Kit, along with the reusable, bedside NeuroModulator™ Development System, and the NeuroTronik CANS Therapy™ Cable. |
Timeline
- Start date
- 2018-06-05
- Primary completion
- 2019-06-01
- Completion
- 2019-07-01
- First posted
- 2018-05-31
- Last updated
- 2018-08-23
Locations
1 site across 1 country: Paraguay
Source: ClinicalTrials.gov record NCT03542123. Inclusion in this directory is not an endorsement.